Clinical Trials Browser

Phase EARLY_PHASE1 × Recurrence × 30 days × Clear all

Multiple Sclerosis, Myasthenia Gravis, Recurrence, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

NCT07574346 2026-05-07

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

Phase EARLY_PHASE1 Not yet recruiting

18 enrolled

Neoplasms, Recurrence

Clinical Trials

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies